                         SEQUENCE LISTING

<110>  CORNING, INC.
 
<120>  SWELLABLE SYNTHETIC MICROCARRIERS

<130>  SP10-173

<150>  US 61/181,776
<151>  2009-05-28

<160>  26    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  1

Lys Gly Gly Asn Gly Glu Pro Arg Gly Asp Thr Tyr Arg Ala Tyr 
1               5                   10                  15  


<210>  2
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  2

Asn Gly Glu Pro Arg Gly Asp Thr Tyr Arg Ala Tyr 
1               5                   10          


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  3

Gly Arg Gly Asp Ser Pro Lys 
1               5           


<210>  4
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  4

Ala Val Thr Gly Arg Gly Asp Ser Pro Ala Ser Ser 
1               5                   10          


<210>  5
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  5

Pro Gln Val Thr Arg Gly Asp Val Phe Thr Met Pro 
1               5                   10          


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  6

Arg Asn Ile Ala Glu Ile Ile Lys Asp Ile 
1               5                   10  


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  7

Lys Tyr Gly Arg Lys Arg Leu Gln Val Gln Leu Ser Ile Arg Thr 
1               5                   10                  15  


<210>  8
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  8

Asn Gly Glu Pro Arg Gly Asp Thr Arg Ala Tyr 
1               5                   10      


<210>  9
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  9

Asn Gly Glu Pro Arg Gly Asp Thr Tyr Arg Ala Tyr 
1               5                   10          


<210>  10
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  10

Lys Tyr Gly Ala Ala Ser Ile Lys Val Ala Val Ser Ala Asp Arg 
1               5                   10                  15  


<210>  11
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  11

Lys Tyr Gly Lys Ala Phe Asp Ile Thr Tyr Val Arg Leu Lys Phe 
1               5                   10                  15  


<210>  12
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  12

Lys Tyr Gly Ser Glu Thr Thr Val Lys Tyr Ile Phe Arg Leu His Glu 
1               5                   10                  15      


<210>  13
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  13

Lys Tyr Gly Thr Asp Ile Arg Val Thr Leu Asn Arg Leu Asn Thr Phe 
1               5                   10                  15      


<210>  14
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide

<400>  14

Thr Ser Ile Lys Ile Arg Gly Thr Tyr Ser Glu Arg 
1               5                   10          


<210>  15
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide

<400>  15

Thr Trp Tyr Lys Ile Ala Phe Gln Arg Asn Arg Lys 
1               5                   10          


<210>  16
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide

<400>  16

Ser Ile Asn Asn Asn Arg Trp His Ser Ile Tyr Ile Thr Arg Phe Gly 
1               5                   10                  15      


Asn Met Gly Ser 
            20  


<210>  17
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide

<400>  17

Lys Tyr Gly Leu Ala Leu Glu Arg Lys Asp His Ser Gly 
1               5                   10              


<210>  18
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide

<400>  18

Gly Gln Lys Cys Ile Val Gln Thr Thr Ser Trp Ser Gln Cys Ser Lys 
1               5                   10                  15      


Ser 
    


<210>  19
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Lysine at residue 4 forms amide bond with Aspartic Acid at 
       residue 17 to cyclize the polypeptide

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Aspartic Acid at residue 17 forms amide bond with Lysine at 
       residue 4 to cyclize the polypeptide

<400>  19

Lys Gly Gly Lys Asp Gly Glu Pro Arg Gly Asp Thr Tyr Arg Ala Thr 
1               5                   10                  15      


Asp 
    


<210>  20
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Leucine at residue 4 forms amide bond with Aspartic Acid at 
       residue 13 to cyclize the polypeptide

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Aspartic Acid at residue 13 forms amide bond with Leucine at 
       residue 4 to cyclize the polypeptide

<400>  20

Lys Gly Gly Leu Glu Pro Arg Gly Asp Thr Tyr Arg Asp 
1               5                   10              


<210>  21
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Cysteine at residue 4 forms a disulfide bond with Cysteine at 
       residue 17 to cyclize the polypeptide

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Cysteine at residue 17 forms a disulfide bond with Cysteine at 
       residue 4 to cyclize the polypeptide

<400>  21

Lys Gly Gly Cys Asn Gly Glu Pro Arg Gly Asp Thr Tyr Arg Ala Thr 
1               5                   10                  15      


Cys 
    


<210>  22
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Cysteine at residue 4 forms a disulfide bond with Cysteine at 
       residue 13 to cyclize the polypeptide

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Cysteine at residue 13 forms a disulfide bond with Cysteine at 
       residue 4 to cyclize the polypeptide

<400>  22

Lys Gly Gly Cys Glu Pro Arg Gly Asp Thr Tyr Arg Cys 
1               5                   10              


<210>  23
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide

<400>  23

Lys Gly Gly Ala Val Thr Gly Asp Gly Asn Ser Pro Ala Ser Ser 
1               5                   10                  15  


<210>  24
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide

<400>  24

Lys Gly Gly Pro Gln Val Thr Arg Gly Asp Val Phe Thr Met Pro 
1               5                   10                  15  


<210>  25
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide

<400>  25

Gly Arg Gly Glu Ser Pro Ile Ile Lys 
1               5                   


<210>  26
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide

<400>  26

Gly Arg Gly Asp Ser 
1               5   


